Stock Price
1.03
Daily Change
0.01 0.98%
Monthly
31.29%
Yearly
-44.32%
Q2 Forecast
1.00

RedHill Biopharma reported $7.1M in Interest Income for its fiscal quarter ending in June of 2023.





Interest Income Change Date
Cara Therapeutics USD 347K 74K Mar/2025
Compugen USD 954K 116K Sep/2025
Cronos Group USD 9.56M 2.18M Dec/2025
RedHill Biopharma USD 7.1M 14.49M Jun/2023